All Type of News
Parliamentary audit to start from Oct. 5
Floor leaders of the ruling Grand National Party and the main opposition Democratic Party decided to convene the parliamentary audit session for 20 days from Oct. 5-24 during a meeting also attended by their deputy fl...
Ahngook wins Norvasc patent suit
Ahngook Pharm got more good news on September 24, as the company said the Supreme Court upheld the company's Korean patent covering the active ingredient in Norvasc, the world's most-prescribed branded medicine for tr...
4 original drugs prices to fall by 20%
The four original drugs, including Lilly’s Zyprexa, Novo Nordisc’s Norditropin SimpleXx and Sanofi Aventis’ Taxotere will be decreased by 20 percent, when their patents are to be expired and corresponding generic drug...
Dongwon severs ties with Zeullig Korea
Dongwon Pharma Group, the nation’s largest pharmaceutical wholesaler with 500 billion won in sales, has recently decided to sever its business relationship with Zuellig Korea amid worsening business conditions.
The...
DTC advertising plan of prescription drugs hits snag
The Ministry of Strategy and Finance has hit a snag with its plan to allow drug makers to advertise prescription drugs at mass media aimed at boosting the local service industry, with most of related parties, includin...
Designation of orphan drugs to be redefined
The government will redefine the designation rule of orphan drugs as part of its efforts to reflect the current market situation, according to the Korea Food and Drug Administration.
Under the current regulation, a...
Hospitals warned of sanction for prolonged drug payment
The Korea Association of Pharmaceutical Wholesaler (KAPW) will toughen its stance on hospitals that delay the drug payment of national pension, its spokesman said recently.
The KAPW said it will seek to legislate a...
Hospira opens Korean branch
The US based Hopira, Inc., global pharmaceutical and drug delivery company, is looking to take a firm presence in the domestic market by setting up its Korean unit.
Tim Oldham, president of Hopira’s Asia-Pacific Bu...
Court ruling to be made available in October
Seoul Central District Court will make its final ruling on redemption suit of medication costs against Yungjin Pharm and Ildong Pharm on October 14.
The court is now in process of reviewing the documents submitted ...
FTC to monitor illegal rebate
The Fair Trade Commission (FTC) said on September 23 that the business regulator will make endeavors to allow a culture of fair trade to take root, citing some types of unfair practices such as price fixing, illicit i...
